Hepatocellular carcinoma arising from hepatocellular adenoma in a hepatitis B virus-associated cirrhotic liver

Clinical Radiology

Volumn 67, Issue 4, 2012, Pages 329-333

  Seo, J M ^a   Lee, S J ^a   Kim, S H ^a   Park, C K ^a   Ha, S Y ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENATE DIMEGLUMINE; HEPATITIS B SURFACE ANTIGEN; TAMOXIFEN CITRATE;

AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER PARENCHYMA; LIVER SURGERY; LIVER TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPLENOMEGALY; THYROID CANCER; THYROIDECTOMY; TUMOR VOLUME;

ADENOMA, LIVER CELL; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASMS, SECOND PRIMARY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84858008574     PISSN: 00099260     EISSN: 1365229X     Source Type: Journal    
DOI: 10.1016/j.crad.2011.09.003     Document Type: Article

References (21)

1. Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 1995;22:983-93.
2. Leese T, Farges O, Bismuth H. Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg 1988;208:558-64. (Pubitemid 18267695)
3. Kerlin P, Davis GL, McGill DB, et al. Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology 1983;84:994-1002. (Pubitemid 13119913)
4. Alshak NS, Cocjin J, Podesta L, et al. Hepatocellular adenoma in glycogen storage disease type IV. Arch Pathol Lab Med 1994;118:88-91. (Pubitemid 24020193)
5. Ghaferi AA, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 2005;129:1348-52. (Pubitemid 40804853)
6. Watkins J, Balabaud C, Bioulac-Sage P, et al. Hepatocellular adenoma in advanced-stage fatty liver disease. Eur J Gastroenterol Hepatol 2009;21:932-6.
7. Tesluk H, Lawrie J. Hepatocellular adenoma. Its transformation to carcinoma in a user of oral contraceptives. Arch Pathol Lab Med 1981;105:296-9. (Pubitemid 11047795)
8. Burri E, Steuerwald M, Cathomas G, et al. Hepatocellular carcinoma in a liver-cell adenoma within a non-cirrhotic liver. Eur J Gastroenterol Hepatol 2006;18:437-41.
9. Barthelmes L, Tait IS. Liver cell adenoma and liver cell adenomatosis. HPB (Oxford) 2005;7:186-96. (Pubitemid 41535849)
10. Tao LC. Oral contraceptive-associated liver cell adenoma and hepatocellular carcinoma. Cytomorphology and mechanism of malignant transformation. Cancer 1991;68:341-7.
11. Ichikawa T, Federle MP, Grazioli L, et al. Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology 2000;214:861-8. (Pubitemid 30115393)
12. Kim DH, Kim SU, Nam DH, et al. A case of hepatocellular carcinoma within hepatocellular adenoma in a non-cirrhotic male. Korean J Intern Med 2009;24:147-52.
13. Carthew P, Rich KJ, Martin EA, et al. DNA damage as assessed by 32Ppostlabelling in three rat strains exposed to dietary tamoxifen: the relationship between cell proliferation and liver tumour formation. Carcinogenesis 1995;16:1299-304.
14. Brown K. Is tamoxifen a genotoxic carcinogen in women? Mutagenesis 2009;24:391-404.
15. Paulson EK, McClellan JS, Washington K, et al. Hepatic adenoma: MR characteristics and correlation with pathologic findings. AJR Am J Roentgenol 1994;163:113-6. (Pubitemid 24225698)
16. Carswell KA, Belgaumkar A, Karani J, et al. Regression of hepatic adenomata after cessation of selective oestrogen receptor modulator. Liver Int 2009;29:73.
17. Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotypeephenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatol 2006;43:515-24.
18. Bioulac-Sage P, Laumonier H, Couchy G, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009;50:481-9.
19. Grazioli L, Morana G, Kirchin MA, et al. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 2005;236:166-77. (Pubitemid 40853309)
20. Narita M, Hatano E, Arizono S, et al. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 2009;44:793-8.
21. Bartolozzi C, Battaglia V, Bozzi E. HCC diagnosis with liver-specific MRIeclose to histopathology. Dig Dis 2009;27:125-30.